Methyl prednisolone Injection versus diclofenac Injection in Treatment of Trigger Finger

Comparison of methyl prednisolone Injection versus diclofenac Injection in Treatment of Trigger Finger

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160508027797N6

Enrollment

Registered

2019-11-24

Start date

2019-08-25

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger Finger. Trigger finger, unspecified finger

Interventions

Intervention 1: Intervention group:Medicines from Abaidi Company are selected for all patients equally. Hemoglobin A1C is measured before treatment was started. 20 mg methylprednisolone acetate inject

Eligibility

Sex/Gender

All

Age

21 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 65-95 years Patients with Trigger Finger Informed consent of patient in the study

Exclusion criteria

Exclusion criteria: Patients who had a history of allergy to Diclofenac or Methylprednisolone. Pregnant or lactating patients and patients who have had a previous history of injection on the same finger. Failure to follow the patient

Design outcomes

Primary

Measure	Time frame
Decrease in Quinnell grade. Timepoint: 3 and 6 weeks, 3 and 6 and 12 months after the first injection. Method of measurement: Quinnell grading.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Sasan Mohammadi Jami

Babol University of Medical Sciences

jamisasan@gmail.com+98 11 3225 6285

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026